+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 12Years +
All Genders
ID06855901

Home Ultra-long-term EEG Monitoring Using a Minimally Invasive Wearable Device for Drug-Resistant Rare Epilepsies and Epileptic Encephalopathies

Led by Azienda Ospedaliero-Universitaria di Modena · Updated on 2025-03-04

30

Participants Needed

4

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with drug-resistant epilepsies, developmental and epileptic encephalopathies DEE, or rare epilepsies to develop a personalized care model using a minimally invasive, wearable, subcutaneous EEG device sqEEG for ultra-long-term monitoring at home. The study aims to assess the devices ability to reliably detect seizures over extended periods, verify automated seizure detection algorithms, and evaluate how the collected data may improve clinical management and treatment outcomes. This approach hopes to reduce hospitalization side effects and provide accurate seizure quantification in real-life settings to enhance quality of life. The study involves two parts an initial short-term inpatient phase where subcutaneous EEG electrodes are implanted by a neurosurgeon and tested alongside standard video-EEG monitoring in an Epilepsy Monitoring Unit. This phase evaluates the devices safety, sensitivity, tolerability, and algorithm accuracy. The second, core part consists of home-based monitoring using the wearable device for at least 12 weeks, with an optional extension up to 24 weeks if deemed beneficial. Participants continue their usual anti-seizure medication adjustments during this time, while device usage and adverse effects are closely tracked. Participants will document seizure events in diaries, supported by caregivers if needed, while weekly reviews of EEG data and safety assessments occur. The study team will compare seizure reports from the device, diaries, and clinical evaluations to determine accuracy and potential impact on patient care. After the home monitoring period, the implanted electrode is removed, and a follow-up visit is planned. Data collected will assess device safety, seizure detection accuracy, and the clinical usefulness of long-term EEG monitoring in managing epilepsy.

CONDITIONS

Brief Title

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

Research Team

S

Stefania Maffei, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here